<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34348533</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>sup1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Single breath counting is an effective screening tool for forced vital capacity in ALS.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>8</EndPage><MedlinePgn>5-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1915337</ELocationID><Abstract><AbstractText><i>Objective</i>: To measure the correlation between single breath counting (SBC) and forced vital capacity (liters, FVC<sub>L</sub>) in amyotrophic lateral sclerosis (ALS) patients and to define the utility of SBC for determining when patients meet the threshold for initiation of noninvasive positive pressure ventilation (FVC &lt; 50% predicted [FVC<sub>pred</sub>]). <i>Methods:</i> Both patient paced (SBCpp) or externally paced (SBCep) counting along with FVC<sub>L+pred</sub> and standard clinical data were collected. Linear regression was used to examine SBCpp and SBCep as a predictor of FVC<sub>L</sub>. Receiver operating characteristic curve analysis evaluated the sensitivity and specificity of SBC categorically predicting FVC<sub>pred</sub> of &#x2264;50%. <i>Results:</i> In 30 ALS patients, SBC explained a moderate proportion of the variance in FVC<sub>L</sub> (SBCpp: <i>R</i><sup>2</sup>= 0.431, <i>p</i>&#x2009;&lt;&#x2009;0.001; SBCep: <i>R</i><sup>2</sup> = 0.511, <i>p</i>&#x2009;&lt;&#x2009;0.01); this proportion improved when including covariates (SBCpp: <i>R</i><sup>2</sup>= 0.635, <i>p</i>&#x2009;&lt;&#x2009;0.01; SBCep: <i>R</i><sup>2</sup>= 0.657, <i>p</i>&#x2009;&lt;&#x2009;0.01). Patients with minimal speech involvement performed similarly in unadjusted (SBCpp: <i>R</i><sup>2</sup> = 0.511, <i>p</i>&#x2009;&lt;&#x2009;0.01; SBCep: <i>R</i><sup>2</sup>= 0.595, <i>p</i>&#x2009;&lt;&#x2009;0.01) and adjusted (SBCpp: <i>R</i><sup>2</sup> = 0.634, <i>p</i>&#x2009;&lt;&#x2009;0.01; SBCep: <i>R</i><sup>2</sup>= 0.650, <i>p</i>&#x2009;&lt;&#x2009;0.01) models. SBCpp had 100% sensitivity and 60% specificity (area under curve (AUC)&#x2009;=&#x2009;0.696) for predicting FVC<sub>pred</sub> &lt;50%. SBCep had 100% sensitivity and 56% specificity (AUC = 0.696). With minimal speech involvement SBCpp and SBCep both had 100% sensitivity and 76.1% specificity (SPCpp: AUC = 0.845; SBCep: AUC = 0.857). <i>Conclusions:</i> SBC explains a moderate proportion of variance in FVC and is an extremely sensitive marker of poor FVC. When FVC cannot be obtained, such as during the current COVID-19 pandemic, SBC is helpful in directing patient care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Colin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0618-5854</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mcmillan</LastName><ForeName>Corey T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owegi</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School/UMass Memorial Medical Center, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almasy</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douthwright</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School/UMass Memorial Medical Center, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mckenna-Yasek</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School/UMass Memorial Medical Center, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Namita A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, Irvine, CA, USA and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Healey Center at Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School/UMass Memorial Medical Center, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Single breath count</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword><Keyword MajorTopicYN="N">ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34348533</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1915337</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>